ESMO ranking of the clinical benefits of new drugs
19 Jun 2017
ESMO ranking of the clinical benefits of new drugs
Cancer and the workplace
The recent past and near future of drug approvals in Europe
Working With Cancer: helping people affected by cancer return to work
Treating the patient, not the disease: in memory of Umberto Veronesi
ShortHER trastuzumab treatment of HER2 breast cancer: 9 weeks v 1 year
Implementing new health initiatives in low-resource environments
Cancer and caring in modern medicine
Recent childhood cancer survivors face less chronic disease risk than previous decades
Hallmarks of cancer cell development
75 years of Tata Memorial Centre
Tobacco, lung cancer and non-smoking lung cancers